Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners at ASMS 2018
News Jun 07, 2018
Credit: Thermo Fisher Scientific
Thermo Fisher Scientific, the world leader in serving science, recognized the winners of the 2018 Thermo Scientific Tandem Mass Tag (TMT) Research Award at the opening of a breakfast workshop held on June 6, 2018, in conjunction with the 66th American Society of Mass Spectrometry (ASMS) Conference in San Diego.
Now in its fourth year, the research competition selects scientists from a pool of international applicants based on innovation and the potential impact of their work in proteomics using TMT. The proprietary TMT reagents are exclusively licensed to Thermo Fisher Scientific by Proteome Sciences, PLC.
Winners receive awards of TMT and other mass spectrometry-related reagents, valued at $10,000, $7,500 and $5,000, at a ceremony that takes place during the annual conference. The scientists will use these awards to quantify, normalize and streamline global protein expression studies using mass spectrometry.
A panel of judges from Thermo Fisher and Proteome Sciences, PLC, reviewed the applications and selected the following four recipients based on the scientific merit of their proposals:
- David-Paul Minde, University of Cambridge, Cambridge, England (Gold Level recipient)
- Sandipan Ray, University College London and the Francis Crick Institute, London, England (Silver Level recipient)
- Sarah Peck, Indiana University of Medicine, Indianapolis, Indiana (co-Bronze Level recipient)
- Edward Emmott, Northeastern University, Boston, Massachusetts (co-Bronze Level recipient)
"We are excited to offer the TMT Research Grant Award for the fourth consecutive year," said Monica O'Hara-Noonan, market development manager, protein and cell analysis, Thermo Fisher. "This year we modified the program to seek applications from graduate and postdoctoral students, and we look forward to seeing what these emerging scientists achieve with our reagents. We received a wide range of diverse submissions which provided us with a thrilling glimpse into the future of multiplex proteomics."